P
Peatness
Guest
World's first malaria vaccine approved for use in children in Africa
WHO’s malaria vaccine study represents a “serious breach of international ethical standards”
Usage of Mosquirix, the world’s first licensed malaria vaccine, is being limited to pilot implementation due to safety concerns including a rate of meningitis in those receiving Mosquirix 10 times that of those who did not, increased cerebral malaria cases, and a doubling in the risk of death...
childrenshealthdefense.org
WHO’s rollout of malaria vaccine in Africa: can safety questions be answered after only 24 months?
### Key messages World malaria day on 23 April 2019 saw the start of the first routine malaria vaccine programme in Africa—a pilot study in Malawi. Ghana and Kenya have now followed. The RTS,S/AS01 malaria vaccine has been under development by GlaxoSmithKline for 30 years and is the first...
www.bmj.com
WHO’s malaria vaccine study represents a “serious breach of international ethical standards”
Experts are troubled by the apparent lack of informed consent in a large, cluster randomised study of the malaria vaccine. Peter Doshi reports A large scale malaria vaccine study led by the World Health Organization has been criticised by a leading bioethicist for committing a “serious breach”...
www.bmj.com